Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hyperlipidaemia and cardiovascular disease--back to basics: dietary patterns, foods and cardiovascular risk.
Dominiczak MH.
Curr Opin Lipidol. 2011 Dec;22(6):509-11. No abstract available.
Related citations
Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?
Nofer JR.
Curr Opin Lipidol. 2011 Aug;22(4):319-21. No abstract available.
Atherosclerosis: cell biology and lipoproteins.
Lu H, Daugherty A.
Curr Opin Lipidol. 2011 Aug;22(4):322-3. No abstract available.
Current world literature.
[No authors listed]
Curr Opin Lipidol. 2011 Aug;22(4):308-10. No abstract available.
Lipoprotein glomerulopathy.
Tsimihodimos V, Elisaf M.
Curr Opin Lipidol. 2011 Aug;22(4):262-9. Review.
Unexpected roles for PCSK9 in lipid metabolism.
Soutar AK.
Curr Opin Lipidol. 2011 Jun;22(3):192-6. Review.
Hepatic fatty acid partitioning.
Hodson L, Frayn KN.
Curr Opin Lipidol. 2011 Jun;22(3):216-24. Review.
Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
Saha SA, Arora RR.
Curr Opin Lipidol. 2011 Aug;22(4):270-6. Review.
Genetic bases of hypertriglyceridemic phenotypes.
Johansen CT, Hegele RA.
Curr Opin Lipidol. 2011 Aug;22(4):247-53. Review.
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
Thompson GR, Catapano A, Saheb S, Atassi-Dumont M, Barbir M, Eriksson M, Paulweber B, Sijbrands E, Stalenhoef AF, Parhofer KG.
Curr Opin Lipidol. 2010 Dec;21(6):492-8. Review.
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC, de Graaf J, van Greevenbroek MM, Schaper N, Stehouwer CD, Stalenhoef AF.
Curr Opin Lipidol. 2010 Dec;21(6):530-8. Review.
Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease.
Curr Opin Lipidol. 2010 Aug;21(4):392-3. No abstract available.
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
Datta BN, McDowell IF, Rees A.
Curr Opin Lipidol. 2010 Aug;21(4):366-71. Review.
Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue.
Karpe F, Chamas L.
Curr Opin Lipidol. 2010 Jun;21(3):282-3. No abstract available.
Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?
Choudhury RP.
Curr Opin Lipidol. 2010 Apr;21(2):161-2. No abstract available.
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
Virani SS, Ballantyne CM.
Curr Opin Lipidol. 2010 Apr;21(2):165-6. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on